Author Correction: Imaging tau and amyloid-β proteinopathies in Alzheimer disease and other conditions

doi:10.1038/s41582-018-0021-z

Published Erratum

. 2018 Jul;14(7):446.

doi: 10.1038/s41582-018-0021-z.

Author Correction: Imaging tau and amyloid-β proteinopathies in Alzheimer disease and other conditions

Victor L Villemagne^{1

2

3}, Vincent Doré^{4

5}, Samantha C Burnham⁶, Colin L Masters⁷, Christopher C Rowe^{4

8

7}

Affiliations

¹ Department of Molecular Imaging and Therapy, Centre for PET, Austin Health, Heidelberg, Victoria, Australia. victorlv@unimelb.edu.au.
² Department of Medicine, University of Melbourne, Austin Health, Heidelberg, Victoria, Australia. victorlv@unimelb.edu.au.
³ The Florey Institute of Neuroscience and Mental Health and University of Melbourne, Parkville, Victoria, Australia. victorlv@unimelb.edu.au.
⁴ Department of Molecular Imaging and Therapy, Centre for PET, Austin Health, Heidelberg, Victoria, Australia.
⁵ CSIRO, Health and Biosecurity Flagship, The Australian eHealth Research Centre, Royal Brisbane and Women's Hospital, Herston, Queensland, Australia.
⁶ eHealth, CSIRO Health and Biosecurity, Melbourne, Parkville, Victoria, Australia.
⁷ The Florey Institute of Neuroscience and Mental Health and University of Melbourne, Parkville, Victoria, Australia.
⁸ Department of Medicine, University of Melbourne, Austin Health, Heidelberg, Victoria, Australia.

PMID: 29880829
DOI: 10.1038/s41582-018-0021-z

Published Erratum

Author Correction: Imaging tau and amyloid-β proteinopathies in Alzheimer disease and other conditions

Victor L Villemagne et al. Nat Rev Neurol. 2018 Jul.

. 2018 Jul;14(7):446.

doi: 10.1038/s41582-018-0021-z.

Authors

Victor L Villemagne^{1

2

3}, Vincent Doré^{4

5}, Samantha C Burnham⁶, Colin L Masters⁷, Christopher C Rowe^{4

8

7}

Affiliations

¹ Department of Molecular Imaging and Therapy, Centre for PET, Austin Health, Heidelberg, Victoria, Australia. victorlv@unimelb.edu.au.
² Department of Medicine, University of Melbourne, Austin Health, Heidelberg, Victoria, Australia. victorlv@unimelb.edu.au.
³ The Florey Institute of Neuroscience and Mental Health and University of Melbourne, Parkville, Victoria, Australia. victorlv@unimelb.edu.au.
⁴ Department of Molecular Imaging and Therapy, Centre for PET, Austin Health, Heidelberg, Victoria, Australia.
⁵ CSIRO, Health and Biosecurity Flagship, The Australian eHealth Research Centre, Royal Brisbane and Women's Hospital, Herston, Queensland, Australia.
⁶ eHealth, CSIRO Health and Biosecurity, Melbourne, Parkville, Victoria, Australia.
⁷ The Florey Institute of Neuroscience and Mental Health and University of Melbourne, Parkville, Victoria, Australia.
⁸ Department of Medicine, University of Melbourne, Austin Health, Heidelberg, Victoria, Australia.

PMID: 29880829
DOI: 10.1038/s41582-018-0021-z

Abstract

In Figure 1 of this article as originally published, the chemical structure at bottom right was incorrectly labelled ¹⁸F-PM-PBB3. The text label has been corrected to ¹⁸F-PBB3 in the PDF and HTML versions of the article. As of this date, the structure of PM-PBB3 (also known as APN-1607) has not yet been published.

PubMed Disclaimer

Erratum for

Imaging tau and amyloid-β proteinopathies in Alzheimer disease and other conditions.
Villemagne VL, Doré V, Burnham SC, Masters CL, Rowe CC. Villemagne VL, et al. Nat Rev Neurol. 2018 Apr;14(4):225-236. doi: 10.1038/nrneurol.2018.9. Epub 2018 Feb 16. Nat Rev Neurol. 2018. PMID: 29449700 Review.

Cited by

Functional Brain Network Connectivity Patterns Associated With Normal Cognition at Old-Age, Local β-amyloid, Tau, and APOE4.
Quevenco FC, van Bergen JM, Treyer V, Studer ST, Kagerer SM, Meyer R, Gietl AF, Kaufmann PA, Nitsch RM, Hock C, Unschuld PG. Quevenco FC, et al. Front Aging Neurosci. 2020 Mar 9;12:46. doi: 10.3389/fnagi.2020.00046. eCollection 2020. Front Aging Neurosci. 2020. PMID: 32210782 Free PMC article.
Discovery and preclinical characterization of [¹⁸F]PI-2620, a next-generation tau PET tracer for the assessment of tau pathology in Alzheimer's disease and other tauopathies.
Kroth H, Oden F, Molette J, Schieferstein H, Capotosti F, Mueller A, Berndt M, Schmitt-Willich H, Darmency V, Gabellieri E, Boudou C, Juergens T, Varisco Y, Vokali E, Hickman DT, Tamagnan G, Pfeifer A, Dinkelborg L, Muhs A, Stephens A. Kroth H, et al. Eur J Nucl Med Mol Imaging. 2019 Sep;46(10):2178-2189. doi: 10.1007/s00259-019-04397-2. Epub 2019 Jul 1. Eur J Nucl Med Mol Imaging. 2019. PMID: 31264169 Free PMC article.

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
Other Literature Sources
- scite Smart Citations
Research Materials
- NCI CPTC Antibody Characterization Program
Miscellaneous
- NCI CPTAC Assay Portal

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Author Correction: Imaging tau and amyloid-β proteinopathies in Alzheimer disease and other conditions

Affiliations

Author Correction: Imaging tau and amyloid-β proteinopathies in Alzheimer disease and other conditions

Authors

Affiliations

Abstract

Erratum for

Similar articles

Cited by

Publication types

LinkOut - more resources

Full Text Sources

Other Literature Sources

Research Materials

Miscellaneous

Abstract

Erratum for

Similar articles

Cited by

Publication types

Related information

LinkOut - more resources

Full Text Sources

Other Literature Sources

Research Materials

Miscellaneous